Panelists: Balance Needed Between Antitrust Law, Patent Quality
By Liza Porteus Viana for Intellectual Property Watch
WASHINGTON, DC - A careful balance must be struck between ensuring the quality of the United States patent system - and the patents themselves - and antitrust law to ensure that new technologies and services can be brought to market, particularly in the pharmaceutical industry, experts said in Washington Monday.
"Imbalance can result in less competition, less innovation," Deborah Garza, deputy assistant attorney general for the Department of Justice's antitrust division, said during a meeting of the Intellectual Property Owners Association.
